← back to search

Hongfan Zhao

Xijing Hospital ·
Area of research
Surgery · Pulmonary and Respiratory Medicine
Research interest
Research interests include Bladder and Urothelial Cancer Treatments, Cancer Immunotherapy and Biomarkers, Renal cell carcinoma treatment, and Ferroptosis and cancer prognosis.
h-index
13
citations
661
works
28
NIH funding
primary concept
email

Recent publications

Sex-specific molecular signature of mouse podocytes in homeostasis and in response to pharmacological challenge with rapamycin
Biology of Sex Differences 2024cited by 1position: middledoi
Expanded Hemodialysis ameliorates uremia-induced impairment of vasculoprotective KLF2 and concomitant proinflammatory priming of endothelial cells through an ERK/AP1/cFOS-dependent mechanism
Frontiers in Immunology 2023cited by 10position: firstdoi
Autoantibodies from patients with kidney allograft vasculopathy stimulate a proinflammatory switch in endothelial cells and monocytes mediated via GPCR-directed PAR1-TNF-α signaling
Frontiers in Immunology 2023cited by 7position: middledoi
Nailfold Videocapillaroscopy for Non-Invasive Assessment of Microcirculation and Prognostic Correlation with Endothelial Dysfunction, Cardiovascular Risk Factors, and Non-HLA Antibodies in Heart Transplant Recipients: A Pilot Study
Journal of Clinical Medicine 2023cited by 6position: middledoi
Native and Oxidized Low-Density Lipoproteins Increase the Expression of the LDL Receptor and the LOX-1 Receptor, Respectively, in Arterial Endothelial Cells
Cells 2022cited by 30position: middledoi
Angiogenic Role of Mesothelium-Derived Chemokine CXCL1 During Unfavorable Peritoneal Tissue Remodeling in Patients Receiving Peritoneal Dialysis as Renal Replacement Therapy
Frontiers in Immunology 2022cited by 17position: middledoi
Autoimmune activation and hypersensitization of the AT1 and ETA receptors contributes to vascular injury in scleroderma renal crisis
Lara D. Veeken 2022cited by 12position: middledoi
Transcriptional Regulation of Thrombin-Induced Endothelial VEGF Induction and Proangiogenic Response
Cells 2021cited by 37position: middledoi
Expanded Hemodialysis Therapy Ameliorates Uremia-Induced Systemic Microinflammation and Endothelial Dysfunction by Modulating VEGF, TNF-α and AP-1 Signaling
Frontiers in Immunology 2021cited by 35position: middledoi
Autoantibodies from Patients with Scleroderma Renal Crisis Promote PAR-1 Receptor Activation and IL-6 Production in Endothelial Cells
International Journal of Molecular Sciences 2021cited by 25position: middledoi
G2019S-LRRK2 Expression Augments  -Synuclein Sequestration into Inclusions in Neurons
Journal of Neuroscience 2016cited by 189position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Rusan Catar · Humboldt-Universität zu Berlin10 papers (2021–2024)Julian Kamhieh‐Milz · Charité - Universitätsmedizin Berlin7 papers (2021–2023)Janusz Witowski · Poznan University of Medical Sciences7 papers (2021–2023)Dashan Wu · Charité - Universitätsmedizin Berlin6 papers (2021–2023)Guido Moll · Humboldt-Universität zu Berlin6 papers (2021–2023)Lei Chen · Guizhou University5 papers (2021–2023)Daniel Zickler · St. Joseph-Krankenhaus5 papers (2021–2023)Christian Luecht · Humboldt-Universität zu Berlin4 papers (2021–2023)Pinchao Wang · Humboldt-Universität zu Berlin4 papers (2023–2024)Ralf Schindler · University of Münster3 papers (2021–2023)Harald Heidecke · Institute of Pathology Celle3 papers (2021–2023)Gabriela Riemekasten · Universitäres Kinderwunschzentrum Lübeck3 papers (2021–2023)Muhammad Imtiaz Ashraf · Humboldt-Universität zu Berlin3 papers (2023–2024)Duska Dragun · Humboldt-Universität zu Berlin3 papers (2021–2023)Klemens Budde · Humboldt-Universität zu Berlin3 papers (2021–2023)Christian Lücht · Charité - Universitätsmedizin Berlin2 papers (2021–2022) · 2 papers (2021–2023)Michèle Simon · Humboldt-Universität zu Berlin2 papers (2021–2021) · 2 papers (2021–2022)Isa Hosp · Humboldt-Universität zu Berlin2 papers (2021–2021)